Please note, from 2023 the Print ISSN is not in active use as this journal is no longer published in print.
Epigenetics publishes international research into heritable changes in gene expression caused by mechanisms other than the modification of the DNA sequence.
The aim of Epigenetics is to provide an unprecedented forum where epigenetic mechanisms and their role in diverse biological processes can be revealed, shared and discussed. Topics covered include (but are not limited to):
DNA methylation
Nucleosome positing and modification
Gene silencing
Imprinting
Chromatin remodeling
Non-coding RNA
Dosage compensation
Epigenetic therapy and diagnostics
Cancer epigenetics
Neuroepigenetics
Epigenetics accepts original research articles, reviews and brief reports.
The journal operates a single anonymized peer review policy.
*Please note that Epigenetics converted to a full Open Access journal from Volume 18 (2023). Previous volumes will continue to provide access through a Pay to Read model.
Journal metrics
Usage
640K annual downloads/views
Citation metrics
2.9 (2023) Impact Factor
Q2 Impact Factor Best Quartile
4.3 (2023) 5 year IF
6.8 (2023) CiteScore (Scopus)
Q2 CiteScore Best Quartile
0.729 (2023) SNIP
1.149 (2023) SJR
Speed/acceptance
19 days avg. from submission to first
decision
76 days avg. from submission to first
post-review decision
11 days avg. from acceptance to online
publication
30% acceptance rate
Understanding and using journal metrics
Journal metrics can be a useful tool for readers, as well as for authors
who are deciding where to submit their next manuscript for publication.
However, any one metric only tells a part of the story of a journal’s
quality and impact. Each metric has its limitations which means that it
should never be considered in isolation, and metrics should be used to
support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside
other qualitative factors such as a journal’s aims & scope, its
readership, and a review of past content published in the journal. In
addition, a single article should always be assessed on its own merits and
never based on the metrics of the journal it was published in.
Usage and acceptance rate data above are for the last full calendar year
and are updated annually in February. Speed data is updated every six
months, based on the prior six months. Citation metrics are updated
annually mid-year. Please note that some journals do not display all of
the following metrics
(find out why).
Usage:
the total number of times articles in the journal were viewed by users
of Taylor & Francis Online in the previous calendar year, rounded to the
nearest thousand.
Citation Metrics
Impact Factor*:
the average number of citations received by articles published in the
journal within a two-year window. Only journals in the Clarivate Science
Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI),
Arts and Humanities Citation Index (AHCI) and the Emerging Sources
Citation Index (ESCI) have an Impact Factor.
Impact Factor Best Quartile*:
the journal’s highest subject category ranking in the Journal Citation
Reports. Q1 = 25% of journals with the highest Impact Factors.
5 Year Impact Factor*:
the average number of citations received by articles in the journal
within a five-year window.
CiteScore (Scopus)†:
the average number of citations received by articles in the journal over
a four-year period.
CiteScore Best Quartile†:
the journal’s highest CiteScore ranking in a Scopus subject category. Q1
= 25% of journals with the highest CiteScores.
SNIP
(Source Normalized Impact per Paper):
the number of citations per paper in the journal, divided by citation
potential in the field.
SJR
(Scimago Journal Rank):
Average number of (weighted) citations in one year, divided by the
number of articles published in the journal in the previous three years.
Speed/acceptance
From submission to first decision:
the average (median) number of days for a manuscript submitted to the
journal to receive a first decision. Based on manuscripts receiving a
first decision in the last six months.
From submission to first post-review decision:
the average (median) number of days for a manuscript submitted to the
journal to receive a first decision if it is sent out for peer review.
Based on manuscripts receiving a post-review first decision in the last
six months.
From acceptance to online publication:
the average (median) number of days from acceptance of a manuscript to
online publication of the Version of Record. Based on articles published
in the last six months.
Acceptance rate:
articles accepted for publication by the journal in the previous
calendar year as percentage of all papers receiving a final decision.
Editor-in-Chief Manel Esteller Josep Carreras Leukaemia Research Institute, Barcelona, ES
Executive Editor Kelly Ross San Diego, CA, US Email: [email protected]
Associate Editors Christopher G. Bell - Barts & The London School of Medicine, QMUL, UK Ramji Bhandari - University of North Carolina at Greensboro, USA Tony Gutschner - Martin Luther University Halle-Wittenberg, DE Peter Hamilton - Virginia Commonwealth University, USA Elizabeth Heller - Penn Epigenetics Institute, Perelman School of Medicine, University of Pennsylvania, USA Juntao Hu - Fudan University, China Mikyeong Lee - NIH, USA Christopher Murgatroyd - Manchester Metropolitan University, UK Adele Murrell - University of Bath, UK Alice Cristina-Rodrigues - University of &São Paolo, Brazil Manuel Rosa-Garrido -University of Alabama at Birmingham Andrew Teschendorff - Shanghai Institute for Nutrition and Health, Chinese Academy of Sciences, China; and UCL Cancer Institute, UK
Editorial Board
Blaine Bartholomew - MD Anderson Cancer Center Marnie Blewitt - the Walter and Eliza Hall Insitute, Australia Frederic Chedin - UC Davis Walter Doerfler - Erlangen University Medical School Dana C. Dolinoy - University of Michigan Melanie Ehrlich - Tulane Cancer Center Sam El-Osta - Epigenetics in Human Health and Disease Laboratory Robert Feil - Montpellier, FR Dennis R. Grayson - University of Illinois Mingzhou Guo - Chinese PLA General Hospital Naoko Hattori - Hoshi University, Japan James G. Herman - University of Pittsburgh Miriam Jasiulionis - University of São Paolo, Brazil Randy L. Jirtle - North Carolina State University Atsushi Kaneda - Chiba University, Japan Ryan Lister - University of Western Australia Victoria Lunyak - Aelan Cell Therapeutics Jennifer Mitchell - University of Toronto, Canada Art Petronis - Centre for Addiction and Mental Health Ana Pombo - Berlin Institute for Medical Systems Biology Felix Recillas-Targa - Universidad Nacional Autónoma de México Keith D. Robertson - Mayo Clinic Carmen Sapienza - Temple University Michael K. Skinner - Washington State University Paul A. Wade - National Institute of Environmental Health Sciences Anton Wutz - Research Institute of Molecular Pathology Timur Yusufzai - Third Rock Ventures Dao-Xiu Zhou - Université Paris Frank Slack - Institute for RNA Medicine, Boston, MA
Editorial Advisory Board Lucia Altucci - Universita degli Studi della Campania Luigi Vanvitelli, Italy Stephan Beck - UCL Cancer Institute, UK Xiaodong Cheng - Emory University School of Medicine, USA Michael Meaney - McGill University, Canada Toshikazu Ushijima - Nationcal Cancer Center Reseach Insitute, Japan Azim Surani - University of Cambridge, UK Moshe Yaniv - Insitut Pasteur, France
Abstracting and indexing
Epigenetics is abstracted/indexed in:
DOAJ
EBSCOhost - Biological Abstracts (Online)
Elsevier BV - BIOBASE - EMBASE - Scopus
National Library of Medicine - PubMed Central (PMC)
Thomson Reuters - Biological Abstracts (Online) - BIOSIS Previews - Science Citation Index Expanded - Web of Science
U.S. National Library of Medicine - PubMed/MEDLINE
Open access
Epigenetics is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
Increase the discoverability and readership of your article
Make an impact and reach new readers, not just those with easy access to a research library
Freely share your work with anyone, anywhere
Comply with funding mandates and meet the requirements of your institution, employer or funder
Rigorous peer review for every open access article
Article Publishing Charges (APC)
To publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis. Discounts and waivers may also be available for researchers in selected countries when publishing in open access journals.
Taylor & Francis make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, Taylor & Francis, our agents (including the editor, any member of the editorial team or editorial board, and any guest editors), and our licensors make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions .
Ready to submit?
Start a new submission or continue a submission in progress
![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/110803/Subject-Sample-2021-Bioscience.jpg"})
![BioTechniques: Stay up to date with the hottest topics in the life sciences...]({"type":"image" , "src" : "/sda/112459/journalad-promotion-biotechniques.png"})